
Keywords: FPC; familial pancreatic cancer; HW; Hardy-Weinberg; IDO2; indoleamine 2,3-dioxygenase-2; PCR; polymerase chain reaction; PDA; pancreatic ductal adenocarcinoma; SNP; single nucleotide polymorphism; TJUH; Thomas Jefferson University Hospital;